Managing Director, Business Innovation, DTCC

Within this role, she oversees business development activities across the DTCC Solutions portfolio, working across the business, and with clients and third-party providers to identify opportunities for new product development as well as potential acquisitions, partnerships and mergers to broaden DTCC’s capabilities. She is also responsible for defining the firm’s strategy for new and emerging technology innovation, leading efforts related to the exploration and experimentation of fintech, and working with her colleagues and the industry to advance dialogue on key topics and develop thought leadership.

She joined the firm in 2015. Prior to DTCC, Jennifer worked at CME Group where she served as Executive Director of OTC Product Management with responsibility for CME’s cleared OTC credit default swaps (CDS) business including growth strategy, business development, and go-to-market activities.

Jennifer has over 25 years of financial markets expertise, including consulting and practical experience as well as the design, development and deployment of business strategies in a dynamic environment. She has extensive product knowledge across the entire product life cycle, including OTC, FX and FX Options, OTC Metals, Stock Lending, OTC Credit Default Swaps, OTC Interest Rate Swaps and Swaptions, OTC Total Return Swaps, F&O, Energy and Equities.

Jennifer currently serves on the Technology Advisory Committee of the U.S. Commodity Futures Trading Commission (CFTC), and is the former Chair of the Enterprise Ethereum Alliance (EEA)’s Banking Working Group. She is a member of SIFMA’s Blockchain Roundtable and is a regular speaker at industry conferences, with past participation at Consensus, SIFMA, ISDA and AMF events.